Journal
JOURNAL OF LIPID RESEARCH
Volume 48, Issue 3, Pages 726-732Publisher
ELSEVIER
DOI: 10.1194/jlr.D600038-JLR200
Keywords
phosphatidylinositol (3,4,5) -trisphosphate; neomycin; phosphoinositide 3-kinase; general receptor for phosphoinositides-1; protein-lipid overlay; neutrophil; p110 gamma; Ras
Categories
Funding
- BBSRC [BB/D013593/1] Funding Source: UKRI
- MRC [G9403619] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/D013593/1] Funding Source: researchfish
- Medical Research Council [G9403619] Funding Source: researchfish
Ask authors/readers for more resources
We describe a novel approach to the relative quantification of phosphatidylinositol (3,4,5)-trisphosphate [Ptdlns(3,4,5)P-3] and its application to measure, in neutrophils, the activation of phosphoinositicle 3-kinase (PI3K). This protein-lipid overlay-based assay allowed us to confirm and extend the observations, first, that N-formyl-methionyl-leucyl-phenylaianine (fMLP) stimulation of primed human neutrophils leads to a transient and biphasic increase in Ptdlns(3,4,5)P-3 levels and, second, that the ability of fMLP to stimulate Ptdlns(3,4,5)P-3 accumulation in neutrophils isolated from mice carrying a Ras-insensitive ('DASAA') knock-in of PI3K gamma (p110 gamma(DASAA/DASAA)) is substantially dependent on the Ras binding domain of PI3K gamma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available